AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
EN
Login
EN
Surge Analysis
/
Athira Pharma Inc.
/
2026-04-21
▲ SURGE
Athira Pharma Inc.
+45.0%
ATHA
NASDAQ
Healthcare
2026-04-21
0.58
Close
0.4
Prev Close
+45.00%
Change
20.1x
Vol Ratio
Why It Surged
No related news available.
Related News
FDA clears Amphastar rival to Atrovent inhaler, 180-day exclusivity
Stocktitan
2026-02-24
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, I
Gurufocus
2026-03-29
Atossa Therapeutics Files Prospectus For Offering $50M Common Shares - Atossa Therapeutics (NASDAQ:ATOS)
Benzinga
2026-02-20
Aurobindo Pharma Announcements/Notices: Latest Sotck/Share Market Notices/Announcements on Aurobindo Pharma, Aurobindo Pharma Stock Split,Bonus, Rights, Re-Structuring, Dividends, Board Meetings, Quarterly Results, Record Date, Ex-Date, Book Closure on BSE/NSE
Moneycontrol
2026-04-08
Dermata Therapeutics shares are trading higher after the U.S. Patent and Trademark Office issued the company a notice of allowance for a U.S. patent titled "COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS" - Dermata Therapeutics (NASDAQ:DRMA)
Benzinga
2026-03-19
Technical Analysis
No technical analysis available.
View Company
Back to Surge Stocks
Athira Pharma Inc. Surged +45.0% on 2026-04-21 — Analysis | Alpha Lenz